These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9888669)

  • 1. Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath.
    Grover R; Grobbelaar AO; Richman PI; Smith PJ
    J Hand Surg Br; 1998 Dec; 23(6):728-31. PubMed ID: 9888669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumours of the tendon sheath: lack of correlation between nm23-H1 expression and recurrence.
    Loréa P; Van De Walle H; Kinnen L; Ledoux P; Moermans JP; Van Den Heule B
    J Hand Surg Br; 2004 Feb; 29(1):67-70. PubMed ID: 14734076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression.
    Indinnimeo M; Giarnieri E; Stazi A; Cicchini C; Brozzetti S; Valli C; Carreca I; Vecchione A
    Cancer Lett; 1997 Jan; 111(1-2):1-5. PubMed ID: 9022121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
    J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cellular proliferative activity on recurrence and local tumour extent of localized giant cell tumour of tendon sheath.
    Kitagawa Y; Ito H; Yokoyama M; Sawaizumi T; Maeda S
    J Hand Surg Br; 2004 Dec; 29(6):604-7. PubMed ID: 15542224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
    Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
    Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
    Lai WW; Wu MH; Yan JJ; Chen FF
    Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
    Lindmark G
    Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
    Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
    Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Patel YV; Shah NG; Ghosh N; Suthar TP; Balar DB
    J Surg Oncol; 1997 Jun; 65(2):111-6. PubMed ID: 9209522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nm23 Expression in choroidal melanoma.
    Bardak Y; Cekiç O; Ayhan A; Günalp I; Bulay O
    Ophthalmic Res; 2000; 32(6):257-60. PubMed ID: 11015036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
    Yoo CH; Noh SH; Kim H; Lee HY; Min JS
    J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23 Protein expression in larynx cancer and the relationship with metastasis.
    Gunduz M; Ayhan A; Gullu I; Onerci M; Hosal AS; Gursel B; Hosal IN; Firat D
    Eur J Cancer; 1997 Dec; 33(14):2338-41. PubMed ID: 9616278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS; Feil G; Bichler KH
    Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the nm23 gene product (NDP kinase) expression in astrocytic neoplasms.
    Nawashiro H; Ozeki Y; Takishima K; Shima K; Chigasaki H
    Acta Neurochir (Wien); 1996; 138(4):445-50. PubMed ID: 8738395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.